EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Gut-Liver Axis: The Role of Intestinal Microbiota and Their Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease

Chao Cui iD, Shuai Gao iD, Jingfei Shi iD, Kai Wang iD

Gut and Liver · 15.07.2025 · 19 (4) · 479-507

DOI: 10.5009/gnl240539 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Gut and Liver, online erschienen am 08.05.2025. Verfasst von Chao Cui und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Liver, Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeLiverFatty LiverNon-alcoholic Fatty Liver DiseaseHumansDisease ProgressionDysbiosisProbioticsFecal Microbiota TransplantationBile Acids and Salts

Stichwörter der Autor:innen

Enterohepatic circulationGastrointestinal microbiomeMetabolomeNon-alcoholic fatty liver diseaseTherapeutics

Substanzen

Bile Acids and Salts

Autor:innen und Institutionen

  • Department of Infectious Disease, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, China.
  • Department of Hepatology, Qilu Hospital of Shandong University, Jinan, China.
  • Department of Clinical and Basic Medicine, Shandong First Medical University, Jinan, China.

ORCID-Profile: Chao Cui, Shuai Gao, Jingfei Shi, Kai Wang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Cui, C., Gao, S., Shi, J., & Wang, K. (2025). Gut-Liver Axis: The Role of Intestinal Microbiota and Their Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. Gut and Liver, 19(4), 479-507. https://doi.org/10.5009/gnl240539

Vancouver

Cui C, Gao S, Shi J, Wang K. Gut-Liver Axis: The Role of Intestinal Microbiota and Their Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. Gut and Liver. 2025;19(4):479-507. doi:10.5009/gnl240539

BibTeX
@article{Cui2025,
  author = {Cui, Chao and Gao, Shuai and Shi, Jingfei and Wang, Kai},
  title = {Gut-Liver Axis: The Role of Intestinal Microbiota and Their Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease},
  journal = {Gut and Liver},
  year = {2025},
  volume = {19},
  number = {4},
  pages = {479--507},
  doi = {10.5009/gnl240539}
}
Kostenlos starten →